Treadmill exercise improved adriamycin-induced nephropathy

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 1, 2012, Pages 15-28

  Peng, Chiung Chi ^a,b   Chen, K C ^c   Lu, H Y ^b   Peng, R Y ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Chronic kidney disease; Doxorubicin (adriamycin); Exercise; Matrix metalloproteinases; Renal fibrosis

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CHOLESTEROL; COLLAGEN; CREATININE; DOXORUBICIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DOXORUBICIN INDUCED CHRONIC KIDNEY DISEASE; DRUG INDUCED DISEASE; ENDURANCE TRAINING; ERYTHROCYTE COUNT; GLOMERULAR STRUCTURE; GLOMERULITIS; HEART PROTECTION; KIDNEY CORTEX; KIDNEY MASS; LEUKOCYTE COUNT; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SIGNAL TRANSDUCTION; THROMBOCYTE COUNT; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ACTINS; ANIMALS; COLLAGEN; CREATININE; DOXORUBICIN; EXERCISE THERAPY; INTERLEUKIN-6; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; SPORTS EQUIPMENT; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84859913755     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jeansson M, Bjorck K, Tenstad O, Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol 2009; 20(1):114-22.
2. Vlassara H, Torreggiani M, Post JB, Zheng F, Uribarri J, Striker GE. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl 2009; 114:S3-11.
3. Wang XH, Du J, Klein JD, Bailey JL, Mitch W. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Intl Soc Nephrol 2009; 76:751-9.
4. Lee VW, Haris DC. Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology 2011; 16:30-8.
5. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214:199-210. (Pubitemid 351160157)
6. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006; 17:2992-8. (Pubitemid 44707759)
7. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19(12):2282-7.
8. Chen A, Sheu LF, Ho YS. et al. Experimental focal segmental glomerulosclerosis in mice. Nephron 1998; 78:440-52. (Pubitemid 28154166)
9. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331:1286-92. (Pubitemid 24333194)
10. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19(1):12-23.
11. Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 2004; 15(4):255-73. (Pubitemid 38781050)
12. Rankin CA, Itoh Y, Tian C, Ziemer DM, Calvet JP, Gattone VH 2nd. Matrix metalloproteinase-2 in a murine model of infantile-type polycystic kidney disease. J Am Soc Nephrol 1999; 10(2):210-7. (Pubitemid 29068059)
13. Dockrell ME, Phanish MK, Hendry BM. TGF-beta auto-induction and connective tissue growth factor expression in human renal tubule epithelial cells requires N-ras. Nephron Exp Nephrol 2009; 112(3):e71-9.
14. Ding Y, Kim JK, Kim SI, Na HJ, Jun SY, Lee SJ, Choi ME. TGF-β1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem 2010; 285(48):37909-19.
15. Kwon DS, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Eur J Cell Biol 2006; 85(11):1189-99. (Pubitemid 44548871)
16. Johansen KL. Exercise in the end-stage renal disease population. J Am Soc Nephrol 2007; 18:1845-54. (Pubitemid 46870321)
17. Carrcro JJ, Yilmaz MI, Lindholm B, Stenvinkel P. Cytokine dysregulation in chronic kidney disease: How can we treat it? Blood Purif 2008; 26:291-9. (Pubitemid 351748064)
18. Teixeira de Lemos E, Reis F, Baptista S, et al. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition 2009; 25(3):330-9.
19. Højbjerre L, Rosenzweig M, Dela F, Bruun JM, Stallknecht B. Acute exercise increases adipose tissue interstitial adiponectin concentration in healthy overweight and lean subjects. Euro J Endocrinol 2007; 157(5):613-23. (Pubitemid 350187378)
20. Bertani T, Poggi A, Pozzoni R, et al. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 1982; 46(1):16-23. (Pubitemid 12167012)
21. Weibel ER. Stereological methods. In: Practical Methods for Biological Morphometry. London: Academic, 1979; p. 51-57.
22. Leber TM, Balkwill FR. Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997; 249:24-8. (Pubitemid 27251938)
23. Wang Y, Wang YP, Tay YC, Harris DC. Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int 2000; 58(4):1797-804.
24. Pedersen BK, Fischer CP. Beneficial health effects of exercise - the role of IL-6 as a myokine. Trends Pharmacol Sci 2007; 28:152-5.
25. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305(15):1553-9.
26. Heldin CH, Westermark B. Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regal 1990; 1:555-66.
27. Rubin K, Tingdtrom A, Hansson G.K, et al. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: Possible implications for development of vascular proliferative lesions. Lancet 1988; i:1353-6.
28. Wu SH, Yang YC, Wang ZM. Role of oxygen radicals in adriamycin-induced nephrosis. Chin Med J (Engl) 1990; 103(4):283-9.
29. Zhu Y, Lu L. Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis. Zhongguo Dang Dai Er Ke Za Zhi 2009; 11:56-60.
30. Aresu L, Benali S, Garbisa S, Gallo E, Castagnaro M. Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition. Histol Histopathol 2011; 26:307-13.